| Dr Ajay Kumar Kaja, MBBS | |
|
1267 Highway 54 W Ste 5200, Fayetteville, GA 30214-2113 | |
| (770) 719-5601 | |
| Not Available |
| Full Name | Dr Ajay Kumar Kaja |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 14 Years |
| Location | 1267 Highway 54 W Ste 5200, Fayetteville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487918694 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD-44612 (Iowa) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 91585 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Fayette Hospital | Fayetteville, GA | Hospital |
| Piedmont Newnan Hospital, Inc | Newnan, GA | Hospital |
| Piedmont Hospital | Atlanta, GA | Hospital |
| Northside Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Cardiology Of Atlanta, Llc | 0345321691 | 402 |
News Archive
Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours - replacing the need to routinely draw blood throughout the day.
Using SARS-CoV-2, a team of scientists from the United States has recently developed a bioengineered bacteriophage T4 nanoparticle structure using CRISPR technology that can be used as a universal platform to produce vaccines.
Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.
Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 3 days ago
| Entity Name | Piedmont Cardiology Of Atlanta, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275729691 PECOS PAC ID: 0345321691 Enrollment ID: O20080114000153 |
News Archive
Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours - replacing the need to routinely draw blood throughout the day.
Using SARS-CoV-2, a team of scientists from the United States has recently developed a bioengineered bacteriophage T4 nanoparticle structure using CRISPR technology that can be used as a universal platform to produce vaccines.
Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.
Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ajay Kumar Kaja, MBBS Po Box 2758, Waterloo, IA 50704-2758 Ph: (319) 235-5390 | Dr Ajay Kumar Kaja, MBBS 1267 Highway 54 W Ste 5200, Fayetteville, GA 30214-2113 Ph: (770) 719-5601 |
News Archive
Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours - replacing the need to routinely draw blood throughout the day.
Using SARS-CoV-2, a team of scientists from the United States has recently developed a bioengineered bacteriophage T4 nanoparticle structure using CRISPR technology that can be used as a universal platform to produce vaccines.
Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.
Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 3 days ago
Carzadean Bernadette Hall, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 185 Franklin Farms Cir, Fayetteville, GA 30214 Phone: 404-216-0132 | |
Vipin Ramprasad Lohiya, M.D. Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1267 Highway 54 W Ste 4200, Fayetteville, GA 30214 Phone: 678-829-1060 Fax: 678-829-1099 | |
Connie Dupre, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1267 Highway 54 W, Suite 5200, Fayetteville, GA 30214 Phone: 770-719-5601 | |
Sushee C Gadde, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1267 Highway 54 W Ste 2200, Fayetteville, GA 30214 Phone: 770-716-0051 Fax: 770-716-0087 | |
Dr. John E Burney, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1265 Highway 54 W, Ste 402, Fayetteville, GA 30214 Phone: 678-817-6550 Fax: 404-350-8795 | |
Dr. Bryan L Woods, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1265 Highway 54 W, Ste 402, Fayetteville, GA 30214 Phone: 770-719-3240 Fax: 770-719-3241 | |
Dr. Arvind Jayaraj Ponnambalam, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1255 Highway 54 W, Fayetteville, GA 30214 Phone: 404-367-3014 |